-
Latin Patriarch to get immediate access to Holy Sepulchre: Netanyahu
-
Russian tanker heads to Cuba despite US oil blockade
-
Woodland takes Houston Open, first win since 2019 US Open
-
Italy's Bezzecchi wins fifth MotoGP in a row by taking US Grand Prix
-
Doue brace leads France past Colombia in friendly
-
Rheinmetall addresses row over CEO's Ukraine 'housewives' comment
-
Hungary's anxious rural voters will decide Orban's fate
-
Defiant Pochettino ready for 'even greater' Portugal test
-
Rohit and Rickelton power Mumbai to IPL win over Kolkata
-
Russian tanker nears Cuba, defying US oil blockade
-
'Project Hail Mary' tops N. America box office for second week
-
Forty new migratory species win international protection: UN body
-
Freed whale gets stranded again on German coast
-
Ter Stegen's World Cup chances 'very slim', says Nagelsmann
-
Pakistan hosts Saudi, Turkey, Egypt for talks on Mideast war
-
Tudor leaves after just seven games as Spurs battle for survival
-
Philipsen sprints to In Flanders Fields victory
-
In Israel, air raid sirens spark anxiety and dilemmas
-
Iran accuses US of plotting ground attack despite diplomatic talk
-
Vingegaard clinches Tour of Catalonia victory
-
Despondent Verstappen questions Formula One future
-
Two more arrests over attempted attack on US bank HQ in Paris
-
Nepal's ex-PM attends court hearing in protest crackdown case
-
Iran parliament speaker says US planning ground attack
-
Despondent Verstappen says Red Bull woes 'not sustainable'
-
Piastri says Japan second place 'as good as a win' for McLaren
-
Nepal's former energy minister arrested in graft probe
-
IOC reinstating gender tests 'a disrespect for women' - Semenya
-
Youngest F1 title leader Antonelli to keep 'raising bar' after Japan win
-
High hopes at China's gateway to North Korea as trains resume
-
Antonelli wins in Japan to become youngest F1 championship leader
-
Mercedes' Antonelli wins Japanese Grand Prix to take lead
-
Germany's WWII munitions a toxic legacy on Baltic Sea floor
-
Iran claims aluminium plant attacks in Gulf as Houthis join war
-
North Korea's Kim oversees test of high-thrust engine: state media
-
Five Apple anecdotes as iPhone maker marks 50 years
-
'Excited' Buttler rejuvenated for IPL after horror T20 World Cup
-
Ship insurers juggle war risks for perilous Gulf route
-
Helplines buzz with alerts from seafarers trapped in war
-
Let's get physical: Singapore's seniors turn to parkour
-
Indian tile makers feel heat of Mideast war energy crunch
-
At 50, Apple confronts its next big challenge: AI
-
Houthis missile attacks on Israel widen Middle East war
-
Massive protests against Trump across US on 'No Kings' day
-
Struggling Force lament missed opportunities after Chiefs defeat
-
US thrashed 5-2 by Belgium in reality check for World Cup hosts
-
$520,000 Cash R&D Tax Refund Received
-
A Bright New Era in Electric Mobility - Accelerating the Future of Energy
-
China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
-
Lakers guard Doncic gets one-game ban for accumulated technicals
The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
E.Flores--AT